Association of blood pressure with cardiovascular outcome and mortality: results from the KNOW-CKD study

Jee Young Lee1, Jung Tak Park1, Young Su Joo1

  • 1Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.

Insights

Optimal blood pressure control is crucial for patients with chronic kidney disease (CKD). This study found a U-shaped association between systolic blood pressure (SBP) and adverse outcomes, indicating risks at both low and high SBP levels.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Epidemiology

Background:

  • Optimal blood pressure (BP) management is vital for reducing cardiovascular events (CVEs) and mortality in chronic kidney disease (CKD) patients.
  • Understanding the precise BP targets is critical for effective therapeutic strategies in CKD.

Purpose of the Study:

  • To investigate the association between systolic blood pressure (SBP) levels and the risk of adverse cardiovascular outcomes and all-cause mortality in patients with CKD.
  • To identify the optimal SBP range for improving clinical outcomes in the CKD population.

Main Methods:

  • Analysis of 2226 participants from the KoreaN cohort study for Outcome in patients With CKD (KNOW-CKD).
  • Systolic blood pressure (SBP) was categorized into five levels: <110, 110-119, 120-129, 130-139, and ≥140 mmHg.
  • Marginal structural models (MSMs) were employed using averaged and most recent time-updated SBPs to assess the primary endpoint (composite of all-cause death or incident CVEs).

Main Results:

  • A U-shaped relationship was observed between averaged SBP and the primary composite outcome.
  • Compared to SBP of 110-119 mmHg, hazard ratios (95% CI) for SBP <110 mmHg were 2.47 (1.48-4.11), and for SBP ≥140 mmHg were 2.19 (1.19-4.01).
  • Similar findings were noted when using the most recent time-updated SBP.

Conclusions:

  • A U-shaped association exists between SBP and adverse clinical outcomes in Korean patients with CKD.
  • The findings emphasize the importance of BP control in CKD, suggesting that SBP <110 mmHg may pose a significant risk.
  • Further research is warranted to establish precise BP management guidelines for CKD patients, considering both hypotension and hypertension.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.5K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.0K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
108